Citation:
Pelletier R, Ng K, Alkabbani W, Labib Y, Mourad N, Gamble J-M. Therapeutic Advances in Drug Safety. Adverse events associated with sodium glucose co-transporter 2 inhibitors: an overview of quantitative systematic reviews [Internet]. 2021;Available from: http://www.scopus.com/inward/record.url?eid=2-s2.0-85099858370&partnerID=MN8TOARS